Insights into the antimicrobial activities and metabolomes of Aquimarina (Flavobacteriaceae, Bacteroidetes) species from the rare marine biosphere

Silva, Sandra Godinho; Paula, Patrícia; Da Silva, José Paulo; Mil-Homens, Dalila; Teixeira, Miguel Cacho; Fialho, Arsénio Mendes; Costa, Rodrigo; Keller-Costa, Tina

http://hdl.handle.net/10400.1/18093

Use this identifier to reference this record.

Name:	Description:	Size:	Format:
marinedrugs-20-00423.pdf		4.08 MB	Adobe PDF	Download

Send Feedback

Authors

Silva, Sandra Godinho

Paula, Patrícia

Da Silva, José Paulo

Mil-Homens, Dalila

Teixeira, Miguel Cacho

Fialho, Arsénio Mendes

Costa, Rodrigo

Keller-Costa, Tina

Abstract(s)

Two novel natural products, the polyketide cuniculene and the peptide antibiotic aquimarin, were recently discovered from the marine bacterial genus Aquimarina. However, the diversity of the secondary metabolite biosynthetic gene clusters (SM-BGCs) in Aquimarina genomes indicates a far greater biosynthetic potential. In this study, nine representative Aquimarina strains were tested for antimicrobial activity against diverse human-pathogenic and marine microorganisms and subjected to metabolomic and genomic profiling. We found an inhibitory activity of most Aquimarina strains against Candida glabrata and marine Vibrio and Alphaproteobacteria species. Aquimarina sp. Aq135 and Aquimarina muelleri crude extracts showed particularly promising antimicrobial activities, amongst others against methicillin-resistant Staphylococcus aureus. The metabolomic and functional genomic profiles of Aquimarina spp. followed similar patterns and were shaped by phylogeny. SM-BGC and metabolomics networks suggest the presence of novel polyketides and peptides, including cyclic depsipeptide-related compounds. Moreover, exploration of the ‘Sponge Microbiome Project’ dataset revealed that Aquimarina spp. possess low-abundance distributions worldwide across multiple marine biotopes. Our study emphasizes the relevance of this member of the microbial rare biosphere as a promising source of novel natural products. We predict that future metabologenomics studies of Aquimarina species will expand the spectrum of known secondary metabolites and bioactivities from marine ecosystems.